Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma

23 Mar 2022

Abstract excerpt

Background: Stomach adenocarcinoma (STAD) is one of the most common tumors. Tumor mutation burden (TMB) has been linked to immunotherapy response. We wanted to see if there was any link between TMB and cancer prognosis. Methods: The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) databases were used to obtain mutation data, gene expression profiles, and clinical data. We looked at the differences...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Gastric Cancer Management and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35399509
DOI: 10.3389/fcell.2022.790920

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach AdenocarcinomaPMID 35399509Read ↗

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.Semantic proximity Read ↗

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer.Semantic proximity Read ↗

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric CancerSemantic proximity Read ↗

Continuous Prediction for Tumor Mutation Burden Based on Transcriptional Data in Gastrointestinal CancersSemantic proximity Read ↗

Tumor Mutation Burden: A Predictive Biomarker for Gastric Cancer ImmunotherapySemantic proximity Read ↗

Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers.Semantic proximity Read ↗

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer.Semantic proximity Read ↗

Pathway Mutation Accumulate Perturbation Score: A prognostic and predictive biomarker for immunotherapy in advanced gastric cancer.Semantic proximity Read ↗

Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.Semantic proximity Read ↗

Influence of Tumor Mutational Burden on Immune-infiltrating Cells in Stomach AdenocarcinomaSemantic proximity Read ↗

FAT4 Mutation is Related to Tumor Mutation Burden and Favorable Prognosis in Gastric CancerSemantic proximity Read ↗

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.